Cholesterol
Volume 2012 (2012), Article ID 923289, 10 pages
http://dx.doi.org/10.1155/2012/923289
Review Article
Lipoprotein(a): Cellular Effects and Molecular Mechanisms
Division of Cardiovascular Medicine, Leeds Institute of Genetics, Health and Therapeutics (LIGHT) and Multidisciplinary Cardiovascular Research Centre (MCRC), University of Leeds, Leeds LS2 9JT, UK
Received 11 June 2012; Accepted 24 July 2012
Academic Editor: Michael Ibrahim
Copyright © 2012 Kirsten Riches and Karen E. Porter. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Linked References
- S. M. Marcovina, M. L. Koschinsky, J. J. Albers, and S. Skarlatos, “Report of the national heart, lung, and blood institute workshop on Lipoprotein(a) and cardiovascular disease: recent advances and future directions,” Clinical Chemistry, vol. 49, no. 11, pp. 1785–1796, 2003. View at Publisher · View at Google Scholar · View at Scopus
- S. Frank, S. Durovic, and G. M. Kostner, “The assembly of lipoprotein Lp(a),” European Journal of Clinical Investigation, vol. 26, no. 2, pp. 109–114, 1996. View at Google Scholar · View at Scopus
- S. P. McCormick, “Lipoprotein(a): biology and clinical importance,” The Clinical Biochemist Reviews, vol. 25, no. 1, pp. 69–80, 2004. View at Google Scholar
- K. Berg, “A new serum type system in man—the Lp system,” Acta Pathologica et Microbiologica Scandinavica, vol. 59, pp. 369–382, 1963. View at Google Scholar · View at Scopus
- G. M. Kostner, P. Avogaro, and G. Cazzolato, “Lipoprotein Lp(a) and the risk for myocardial infarction,” Atherosclerosis, vol. 38, no. 1-2, pp. 51–61, 1981. View at Google Scholar · View at Scopus
- G. H. Dahlen, J. R. Guyton, M. Attar, J. A. Farmer, J. A. Kautz, and A. M. Gotto Jr, “Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography,” Circulation, vol. 74, no. 4, pp. 758–765, 1986. View at Google Scholar · View at Scopus
- Y. Yano, K. Shimokawa, Y. Okada, and A. Noma, “Immunolocalization of lipoprotein(a) in wounded tissues,” Journal of Histochemistry and Cytochemistry, vol. 45, no. 4, pp. 559–568, 1997. View at Google Scholar · View at Scopus
- A. von Zychlinski, T. Kleffmann, M. J. A. Williams, and S. P. McCormick, “Proteomics of Lipoprotein(a) identifies a protein complement associated with response to wounding,” Journal of Proteomics, vol. 74, no. 12, pp. 2881–2891, 2011. View at Publisher · View at Google Scholar
- G. Lippi and G. Targher, “Optimal therapy for reduction of lipoprotein(a),” Journal of Clinical Pharmacy and Therapeutics, vol. 37, no. 1, pp. 1–3, 2012. View at Publisher · View at Google Scholar
- G. Davì and C. Patrono, “Mechanisms of disease: platelet activation and atherothrombosis,” New England Journal of Medicine, vol. 357, no. 24, pp. 2482–2494, 2007. View at Publisher · View at Google Scholar · View at Scopus
- M. L. Rand, W. Sangrar, M. A. Hancock et al., “Apolipoprotein(a) enhances platelet responses to the thrombin receptor- activating peptide SFLLRN,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 9, pp. 1393–1399, 1998. View at Google Scholar · View at Scopus
- C. Martínez, J. Rivera, S. Loyau et al., “Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation,” Thrombosis and Haemostasis, vol. 85, no. 4, pp. 686–693, 2001. View at Google Scholar · View at Scopus
- A. Gries, M. Gries, H. Wurm et al., “Lipoprotein(a) inhibits collagen-induced aggregation of thrombocytes,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 5, pp. 648–655, 1996. View at Google Scholar · View at Scopus
- L. D. Tsironis, J. V. Mitsios, H. J. Milionis, M. Elisaf, and A. D. Tselepis, “Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase,” Cardiovascular Research, vol. 63, no. 1, pp. 130–138, 2004. View at Publisher · View at Google Scholar · View at Scopus
- S. A. P. Karabina, M. C. Elisaf, J. Goudevenos, K. C. Siamopoulos, D. Sideris, and A. D. Tselepis, “PAF-acetylhydrolase activity on Lp(a) before and during Cu2+-induced oxidative modification in vitro,” Atherosclerosis, vol. 125, no. 1, pp. 121–134, 1996. View at Publisher · View at Google Scholar · View at Scopus
- D. E. Barre, “Apoprotein (a) antagonises the GPIIb/IIIa receptor on collagen and ADP-stimulated human platelets,” Frontiers in Bioscience, vol. 9, pp. 404–410, 2004. View at Google Scholar · View at Scopus
- E. Malle, A. Ibovnik, A. Steinmetz, G. M. Kostner, and W. Sattler, “Identification of glycoprotein IIb as the lipoprotein(a)-binding protein on platelets: Lipoprotein(a) binding is independent of an arginyl-glycyl- aspartate tripeptide located in apolipoprotein(a),” Arteriosclerosis and Thrombosis, vol. 14, no. 3, pp. 345–352, 1994. View at Google Scholar · View at Scopus
- N. Mackman, “Role of tissue factor in hemostasis, thrombosis, and vascular development,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 6, pp. 1015–1022, 2004. View at Publisher · View at Google Scholar · View at Scopus
- S. N. Sotiriou, V. V. Orlova, N. Al-Fakhri et al., “Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin,” FASEB Journal, vol. 20, no. 3, pp. 559–561, 2006. View at Publisher · View at Google Scholar · View at Scopus
- O. R. Etingin, D. P. Hajjar, K. A. Hajjar, P. C. Harpel, and R. L. Nachman, “Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells: a potential mechanism in thrombogenesis,” Journal of Biological Chemistry, vol. 266, no. 4, pp. 2459–2465, 1991. View at Google Scholar · View at Scopus
- N. M. Caplice, C. Panetta, T. E. Peterson et al., “Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis,” Blood, vol. 98, no. 10, pp. 2980–2987, 2001. View at Publisher · View at Google Scholar · View at Scopus
- M. A. Hancock, M. B. Boffa, S. M. Marcovina, M. E. Nesheim, and M. L. Koschinsky, “Inhibition of plasminogen activation by lipoprotein(a). Critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces,” Journal of Biological Chemistry, vol. 278, no. 26, pp. 23260–23269, 2003. View at Publisher · View at Google Scholar · View at Scopus
- J. Loscalzo, M. Weinfeld, G. M. Fless, and A. M. Scanu, “Lipoprotein(a), fibrin binding, and plasminogen activation,” Arteriosclerosis, vol. 10, no. 2, pp. 240–245, 1990. View at Google Scholar · View at Scopus
- D. Rouy, P. Grailhe, F. Nigon, J. Chapman, and E. Angles-Cano, “Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator: in vitro studies in a plasma milieu,” Arteriosclerosis and Thrombosis, vol. 11, no. 3, pp. 629–638, 1991. View at Google Scholar · View at Scopus
- E. G. Levin, L. A. Miles, G. M. Fless et al., “Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells,” Arteriosclerosis and Thrombosis, vol. 14, no. 3, pp. 438–442, 1994. View at Google Scholar · View at Scopus
- J. Zhang, S. Ren, and G. X. Shen, “Glycation amplifies lipoprotein(a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells,” Atherosclerosis, vol. 150, no. 2, pp. 299–308, 2000. View at Publisher · View at Google Scholar · View at Scopus
- S. Ren, S. Shatadal, and G. X. Shen, “Protein kinase C-β mediates lipoprotein-induced generation of PAI-1 from vascular endothelial cells,” American Journal of Physiology-Endocrinology and Metabolism, vol. 278, no. 4, pp. E656–E662, 2000. View at Google Scholar · View at Scopus
- S. Ren, R. Y. K. Man, A. Angel, and G. X. Shen, “Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells,” Atherosclerosis, vol. 128, no. 1, pp. 1–10, 1997. View at Publisher · View at Google Scholar · View at Scopus
- R. M. Lyons, L. E. Gentry, A. F. Purchio, and H. L. Moses, “Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin,” Journal of Cell Biology, vol. 110, no. 4, pp. 1361–1367, 1990. View at Google Scholar · View at Scopus
- G. K. Owens, A. A. T. Geisterfer, Y. Wei-Hwa Yang, and A. Komoriya, “Transforming growth factor-β-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells,” Journal of Cell Biology, vol. 107, no. 2, pp. 771–780, 1988. View at Google Scholar · View at Scopus
- R. L. Heimark, D. R. Twardzik, and S. M. Schwartz, “Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets,” Science, vol. 233, no. 4768, pp. 1078–1080, 1986. View at Google Scholar · View at Scopus
- Y. Suzuki, T. Tanigaki, D. Heimer et al., “TGF-β1 causes increased endothelial ICAM-1 expression and lung injury,” Journal of Applied Physiology, vol. 77, no. 3, pp. 1281–1287, 1994. View at Google Scholar · View at Scopus
- R. Ramharack, D. Barkalow, and M. A. Spahr, “Dominant negative effect of TGF-β1 and TNF-α on basal and IL-6- induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 6, pp. 984–990, 1998. View at Google Scholar · View at Scopus
- S. Kojima, P. C. Harpel, and D. B. Rifkin, “Lipoprotein (a) inhibits the generation of transforming growth factor β: an endogenous inhibitor of smooth muscle cell migration,” Journal of Cell Biology, vol. 113, no. 6, pp. 1439–1445, 1991. View at Google Scholar · View at Scopus
- M. Miyata, S. Biro, H. Kaieda, and H. Tanaka, “Lipoprotein(a) stimulates the proliferation of cultured human arterial smooth muscle cells through two pathways,” FEBS Letters, vol. 377, no. 3, pp. 493–496, 1995. View at Publisher · View at Google Scholar · View at Scopus
- C. H. O'Neil, M. B. Boffa, M. A. Hancock, J. G. Pickering, and M. L. Koschinsky, “Stimulation of vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor-β activation and on the presence of kringle IV type 9,” Journal of Biological Chemistry, vol. 279, no. 53, pp. 55187–55195, 2004. View at Publisher · View at Google Scholar · View at Scopus
- L. Liu, A. W. Craig, H. D. Meldrum, S. M. Marcovina, B. E. Elliott, and M. L. Koschinsky, “Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin αVβ3,” Biochemical Journal, vol. 418, no. 2, pp. 325–336, 2009. View at Publisher · View at Google Scholar · View at Scopus
- I. E. Koutroubakis, N. Malliaraki, E. Vardas et al., “Increased levels of lipoprotein (a) in Crohn's disease: a relation to thrombosis?” European Journal of Gastroenterology and Hepatology, vol. 13, no. 12, pp. 1415–1419, 2001. View at Publisher · View at Google Scholar · View at Scopus
- H. Azuma, H. Yamaguchi, N. Mima et al., “An in vitro system for identifying agents capable of changing serum lipoprotein(a) concentration by regulating the transcriptional activity of the apolipoprotein(a) gene promoter,” Biochemical and Biophysical Research Communications, vol. 227, no. 2, pp. 570–575, 1996. View at Publisher · View at Google Scholar · View at Scopus
- A. D. MBewu, P. N. Durrington, S. Bulleid, and M. I. Mackness, “The immediate effect of streptokinase on serum lipoprotein(a) concentation and the effect of myocardial infarction on serum lipoprotein(a), apolipoproteins A1 and B, lipids and C-reactive protein,” Atherosclerosis, vol. 103, no. 1, pp. 65–71, 1993. View at Publisher · View at Google Scholar · View at Scopus
- S. Tsimikas, C. Bergmark, R. W. Beyer et al., “Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes,” Journal of the American College of Cardiology, vol. 41, no. 3, pp. 360–370, 2003. View at Publisher · View at Google Scholar · View at Scopus
- S. Tsimikas, H. K. Lau, K. R. Han et al., “Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein,” Circulation, vol. 109, no. 25, pp. 3164–3170, 2004. View at Google Scholar · View at Scopus
- S. Tsimikas, E. S. Brilakis, E. R. Miller et al., “Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease,” New England Journal of Medicine, vol. 353, no. 1, pp. 46–57, 2005. View at Publisher · View at Google Scholar · View at Scopus
- C. Edelstein, D. Pfaffinger, J. Hinman et al., “Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a),” Journal of Biological Chemistry, vol. 278, no. 52, pp. 52841–52847, 2003. View at Publisher · View at Google Scholar · View at Scopus
- C. Edelstein, B. Philips, D. Pfaffinger, and A. M. Scanu, “The oxidized phospholipids linked to human apolipoprotein(a) do not derive from circulating low-density lipoproteins and are probably of cellular origin,” FASEB Journal, vol. 23, no. 3, pp. 950–956, 2009. View at Publisher · View at Google Scholar · View at Scopus
- C. Bergmark, A. Dewan, A. Orsoni et al., “A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma,” Journal of Lipid Research, vol. 49, no. 10, pp. 2230–2239, 2008. View at Publisher · View at Google Scholar · View at Scopus
- O. Klezovitch, C. Edelstein, and A. M. Scanu, “Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a): evidence for a critical involvement of elements in its C-terminal domain,” Journal of Biological Chemistry, vol. 276, no. 50, pp. 46864–46869, 2001. View at Publisher · View at Google Scholar · View at Scopus
- F. Nakagami, H. Nakagami, M. K. Osako et al., “Estrogen attenuates vascular remodeling in Lp(a) transgenic mice,” Atherosclerosis, vol. 211, no. 1, pp. 41–47, 2010. View at Publisher · View at Google Scholar · View at Scopus
- D. J. Suk, N. Rifai, J. E. Buring, and P. M. Ridker, “Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events,” Journal of the American College of Cardiology, vol. 52, no. 2, pp. 124–131, 2008. View at Publisher · View at Google Scholar · View at Scopus
- D. Boffelli, D. A. Zajchowski, Z. Yang, and R. M. Lawn, “Estrogen modulation of apolipoprotein(a) expression: identification of a regulatory element,” Journal of Biological Chemistry, vol. 274, no. 22, pp. 15569–15574, 1999. View at Publisher · View at Google Scholar · View at Scopus
- N. S. Haque, X. Zhang, D. L. French et al., “CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells,” Circulation, vol. 102, no. 7, pp. 786–792, 2000. View at Google Scholar · View at Scopus
- F. Kronenberg, M. F. Kronenberg, S. Kiechl et al., “Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the bruneck study,” Circulation, vol. 100, no. 11, pp. 1154–1160, 1999. View at Google Scholar · View at Scopus
- T. Syrovets, J. Thillet, M. J. Chapman, and T. Simmet, “Lipoprotein(a) is a potent chemoattractant for human peripheral monocytes,” Blood, vol. 90, no. 5, pp. 2027–2036, 1997. View at Google Scholar · View at Scopus
- A. Kagawa, H. Azuma, M. Akaike, Y. Kanagawa, and T. Matsumoto, “Aspirin reduces apolipoprotein(a) (Apo(a)) production in human hepatocytes by suppression of Apo(a) gene transcription,” Journal of Biological Chemistry, vol. 274, no. 48, pp. 34111–34115, 1999. View at Publisher · View at Google Scholar · View at Scopus
- S. Allen, S. Khan, S. P. Tam, M. Koschinsky, P. Taylor, and M. Yacoub, “Expression of adhesion molecules by Lp(a): a potential novel mechanism for its atherogenicity,” FASEB Journal, vol. 12, no. 15, pp. 1765–1776, 1998. View at Google Scholar · View at Scopus
- S. Takami, S. Yamashita, S. Kihara et al., “Lipoprotein(a) enhances the expression of intercellular adhesion molecule-1 in cultured human umbilical vein endothelial cells,” Circulation, vol. 97, no. 8, pp. 721–728, 1998. View at Google Scholar · View at Scopus
- R. Ross, “Atherosclerosis—an inflammatory disease,” New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
- D. J. Grainger, H. L. Kirschenlohr, J. C. Metcalfe, P. L. Weissberg, D. P. Wade, and R. M. Lawn, “Proliferation of human smooth muscle cells promoted by lipoprotein(a),” Science, vol. 260, no. 5114, pp. 1655–1658, 1993. View at Google Scholar · View at Scopus
- R. Locher, R. P. Brandes, W. Vetter, and M. Barton, “Native LDL induces proliferation of human vascular smooth muscle cells via redox-mediated activation of ERK 1/2 mitogen-activated protein kinases,” Hypertension, vol. 39, no. 2, pp. 645–650, 2002. View at Publisher · View at Google Scholar · View at Scopus
- T. Makita, A. Tanaka, and F. Numano, “Effect of glycated low density lipoprotein on smooth muscle cell proliferation,” International Angiology, vol. 18, no. 4, pp. 331–334, 1999. View at Google Scholar · View at Scopus
- S. Mitra, T. Goyal, and J. L. Mehta, “Oxidized LDL, LOX-1 and atherosclerosis,” Cardiovascular Drugs and Therapy, vol. 25, no. 5, pp. 419–429, 2011. View at Publisher · View at Google Scholar
- N. Komai, R. Morishita, S. Yamada et al., “Mitogenic activity of oxidized lipoprotein (a) on human vascular smooth muscle cells,” Hypertension, vol. 40, no. 3, pp. 310–314, 2002. View at Publisher · View at Google Scholar · View at Scopus
- S. P. Zhao and D. Y. Xu, “Oxidized lipoprotein(a) increases the expression of platelet-derived growth factor-B in human umbilical vein endothelial cells,” Clinica Chimica Acta, vol. 296, no. 1-2, pp. 121–133, 2000. View at Publisher · View at Google Scholar · View at Scopus
- A. Takahashi, T. Taniguchi, Y. Fujioka, Y. Ishikawa, and M. Yokoyama, “Effects of lipoprotein(a) and low density lipoprotein on growth of mitogen-stimulated human umbilical vein endothelial cells,” Atherosclerosis, vol. 120, no. 1-2, pp. 93–99, 1996. View at Publisher · View at Google Scholar · View at Scopus
- Y. Yano, M. Seishima, Y. Tokoro, and A. Noma, “Stimulatory effects of lipoprotein(a) and low-density lipoprotein on human umbilical vein endothelial cell migration and proliferation are partially mediated by fibroblast growth factor-2,” Biochimica et Biophysica Acta, vol. 1393, no. 1, pp. 26–34, 1998. View at Publisher · View at Google Scholar · View at Scopus
- U. F. Mondorf, A. Piiper, M. Herrero et al., “Lipoprotein(a) stimulates growth of human mesangial cells and induces activation of phospholipase C via pertussis toxin-sensitive G proteins,” Kidney International, vol. 55, no. 4, pp. 1359–1366, 1999. View at Publisher · View at Google Scholar · View at Scopus
- A. Krämer-Guth, S. Greiber, H. Pavenstädt et al., “Interaction of native and oxidized lipoprotein(a) with human mesangial cells and matrix,” Kidney International, vol. 49, no. 5, pp. 1250–1261, 1996. View at Google Scholar · View at Scopus
- J. Galle, R. Schneider, A. Heinloth et al., “Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress,” Kidney International, vol. 55, no. 4, pp. 1450–1461, 1999. View at Publisher · View at Google Scholar · View at Scopus
- T. A. Seimon, M. J. Nadolski, X. Liao et al., “Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress,” Cell Metabolism, vol. 12, no. 5, pp. 467–482, 2010. View at Publisher · View at Google Scholar · View at Scopus
- T. Cho, Y. Jung, and M. L. Koschinsky, “Apolipoprotein(a), through its strong lysine-binding site in KIV 10, mediates increased endothelial cell contraction and permeability via a Rho/Rho kinase/MYPT1-dependent pathway,” Journal of Biological Chemistry, vol. 283, no. 45, pp. 30503–30512, 2008. View at Publisher · View at Google Scholar · View at Scopus
- S. Etienne-Manneville and A. Hall, “Rho GTPases in cell biology,” Nature, vol. 420, no. 6916, pp. 629–635, 2002. View at Publisher · View at Google Scholar · View at Scopus
- M. Pellegrino, E. Furmaniak-Kazmierczak, J. C. LeBlanc et al., “The apolipoprotein(a) component of Lipoprotein(a) stimulates actin stress fiber formation and loss of cell-cell contact in cultured endothelial cells,” Journal of Biological Chemistry, vol. 279, no. 8, pp. 6526–6533, 2004. View at Publisher · View at Google Scholar · View at Scopus
- A. Scherberich, M. Campos-Toimil, P. Rondé, K. Takeda, and A. Beretz, “Migration of human vascular smooth muscle cells involves serum-dependent repeated cytosolic calcium transients,” Journal of Cell Science, vol. 113, no. 4, pp. 653–662, 2000. View at Google Scholar · View at Scopus
- S. N. Pokrovsky, M. V. Ezhov, L. N. Il'Ina et al., “Association of lipoprotein(a) excess with early vein graft occlusions in middle-aged men undergoing coronary artery bypass surgery,” Journal of Thoracic and Cardiovascular Surgery, vol. 126, no. 4, pp. 1071–1075, 2003. View at Publisher · View at Google Scholar · View at Scopus